SLC6A9 and non-small cell lung carcinoma: The results showed that GLYT1 knockdown and also pharmacological inhibition of this transporter reduced glycine uptake and consequently cell proliferation of fast growing Non-Small Cell Lung Cancer (NSCLC) and colorectal tumour cells, A549 and HT29, respectively.